Tech Company Financing Transactions
Actym Therapeutics Funding Round
Boehringer Ingelheim Venture Fund, Panacea Capital Advisors and Illumina Ventures joined a $34 million Series A funding round for Actym Therapeutics. The financing closed on 4/28/2020.
Transaction Overview
Boehringer Ingelheim Venture Fund (Lead Investor) (Kanad Das)
Panacea Capital Advisors (Lead Investor) (James Huang)
Illumina Ventures (Alexis Ji)
Company Information
Berkeley, CA 94710
USA
Management Team
Browse more venture capital transactions:
Prev: 4/28/2020: Rome Therapeutics venture capital transaction
Next: 4/29/2020: Docupace Technologies venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs